<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36899824</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">688</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12050688</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a few months after the initial infection and develop post-acute sequelae of SARS-CoV-2 (PASC), referred to as "Long-COVID," characterized by persistent physical and mental fatigue. However, the exact pathogenetic mechanisms affecting the brain are still not well-understood. There is increasing evidence of neurovascular inflammation in the brain. However, the precise role of the neuroinflammatory response that contributes to the disease severity of COVID-19 and long COVID pathogenesis is not clearly understood. Here, we review the reports that the SARS-CoV-2 spike protein can cause blood-brain barrier (BBB) dysfunction and damage neurons either directly, or via activation of brain mast cells and microglia and the release of various neuroinflammatory molecules. Moreover, we provide recent evidence that the novel flavanol eriodictyol is particularly suited for development as an effective treatment alone or together with oleuropein and sulforaphane (ViralProtek<sup>&#xae;</sup>), all of which have potent anti-viral and anti-inflammatory actions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theoharides</LastName><ForeName>Theoharis C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-1598-460X</Identifier><AffiliationInfo><Affiliation>Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempuraj</LastName><ForeName>Duraisamy</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1148-8681</Identifier><AffiliationInfo><Affiliation>Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword><Keyword MajorTopicYN="N">toll-like receptors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36899824</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pii">cells12050688</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi S., Alysandratos K.D., Angelidou A., Miniati A., Sismanopoulos N., Vasiadi M., Zhang B., Kalogeromitros D., Theoharides T.C. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J. Investig. Dermatol. 2012;132:324&#x2013;329. doi: 10.1038/jid.2011.334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2011.334</ArticleId><ArticleId IdType="pmc">PMC3471564</ArticleId><ArticleId IdType="pubmed">22089831</ArticleId></ArticleIdList></Reference><Reference><Citation>Canna S.W., Cron R.Q. Highways to hell: Mechanism-based management of cytokine storm syndromes. J. Allergy Clin. Immunol. 2020;146:949&#x2013;959. doi: 10.1016/j.jaci.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7522622</ArticleId><ArticleId IdType="pubmed">33007328</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.E., Katsaounou P., et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020;27:992&#x2013;1000.e1003. doi: 10.1016/j.chom.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Paces J., Strizova Z., Smrz D., Cerny J. COVID-19 and the immune system. Physiol. Res. 2020;69:379&#x2013;388. doi: 10.33549/physiolres.934492.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.934492</ArticleId><ArticleId IdType="pmc">PMC8648321</ArticleId><ArticleId IdType="pubmed">32469225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Copaescu A., Smibert O., Gibson A., Phillips E.J., Trubiano J.A. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J. Allergy Clin. Immunol. 2020;146:518&#x2013;534.e511. doi: 10.1016/j.jaci.2020.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7471766</ArticleId><ArticleId IdType="pubmed">32896310</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473&#x2013;474. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T., Jurinovic V., Arnreich C., Lipworth B.J., Hellmuth J.C., von Bergwelt-Baildon M., Klein M., Weinberger T. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J. Allergy Clin. Immunol. 2020;146:128&#x2013;136.e124. doi: 10.1016/j.jaci.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Shoenfeld Y. Post-COVID syndrome: The aftershock of SARS-CoV-2. Int. J. Infect. Dis. 2022;114:233&#x2013;235. doi: 10.1016/j.ijid.2021.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.020</ArticleId><ArticleId IdType="pmc">PMC8590600</ArticleId><ArticleId IdType="pubmed">34785367</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Conti P. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome? J. Biol. Regul. Homeost. Agents. 2020;34:1633&#x2013;1636. doi: 10.23812/20-EDIT3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-EDIT3</ArticleId><ArticleId IdType="pubmed">33023287</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Potential association of mast cells with coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2021;126:217&#x2013;218. doi: 10.1016/j.anai.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7644430</ArticleId><ArticleId IdType="pubmed">33161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 2020;46:306&#x2013;308. doi: 10.1002/biof.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1633</ArticleId><ArticleId IdType="pmc">PMC7267424</ArticleId><ArticleId IdType="pubmed">32339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ongur D., Perlis R., Goff D. Psychiatry and COVID-19. JAMA. 2020;324:1149&#x2013;1150. doi: 10.1001/jama.2020.14294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.14294</ArticleId><ArticleId IdType="pubmed">32960247</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav. Immun. 2020;89:531&#x2013;542. doi: 10.1016/j.bbi.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferbaum B., North C.S. Mental Health and the COVID-19 Pandemic. N. Engl. J. Med. 2020;383:510&#x2013;512. doi: 10.1056/NEJMp2008017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2008017</ArticleId><ArticleId IdType="pubmed">32283003</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y.T., Yang Y., Li W., Zhang L., Zhang Q., Cheung T., Ng C.H. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228&#x2013;229. doi: 10.1016/S2215-0366(20)30046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30046-8</ArticleId><ArticleId IdType="pmc">PMC7128153</ArticleId><ArticleId IdType="pubmed">32032543</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S.P., Tsoporis J.N., Spandidos D.A., et al. Long COVID and neuropsychiatric manifestations (Review) Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J.B., Rengasamy E.R., Watson C., Jansen K., Chakraborty S., Sundaram R.D., Hafeez D., Burchill E., Saini A., Thomas L., et al. Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Commun. 2022;4:fcab297. doi: 10.1093/braincomms/fcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Yuan K., Wang Z., Liu W.J., Lu Z.A., Liu L., Shi L., Yan W., Yuan J.L., Li J.L., et al. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl. Psychiatry. 2021;11:499. doi: 10.1038/s41398-021-01629-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01629-8</ArticleId><ArticleId IdType="pmc">PMC8482959</ArticleId><ArticleId IdType="pubmed">34593760</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyzoidis S., Koletsa T., Panagiotidou S., Ashkan K., Theoharides T.C. Mast cells in meningiomas and brain inflammation. J. Neuroinflamm. 2015;12:170. doi: 10.1186/s12974-015-0388-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0388-3</ArticleId><ArticleId IdType="pmc">PMC4573939</ArticleId><ArticleId IdType="pubmed">26377554</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Mast cells: The immune gate to the brain. Life Sci. 1990;46:607&#x2013;617. doi: 10.1016/0024-3205(90)90129-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(90)90129-F</ArticleId><ArticleId IdType="pubmed">2407920</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Wang Y.W., Ni P.F., Chen Y.N., Dong H.Q., Qian Y.N. Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2. J. Neuroinflamm. 2018;15:248. doi: 10.1186/s12974-018-1287-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1287-1</ArticleId><ArticleId IdType="pmc">PMC6119285</ArticleId><ArticleId IdType="pubmed">30170602</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Giannetti M.P., Weller E., Hamilton M.J., Castells M. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy. Ann. Allergy Asthma Immunol. 2022;128:299&#x2013;306. doi: 10.1016/j.anai.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.10.006</ArticleId><ArticleId IdType="pubmed">34648976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu J.K., Kulka M. Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:1093. doi: 10.3390/ijms22031093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031093</ArticleId><ArticleId IdType="pmc">PMC7865982</ArticleId><ArticleId IdType="pubmed">33499208</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Facci L., Giusti P. Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: A review. CNS Neurol. Disord. Drug Targets. 2014;13:1654&#x2013;1666. doi: 10.2174/1871527313666141130224206.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527313666141130224206</ArticleId><ArticleId IdType="pubmed">25470401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron R.Q., Goyal G., Chatham W.W. Cytokine Storm Syndrome. Annu. Rev. Med. 2022;74:321&#x2013;337. doi: 10.1146/annurev-med-042921-112837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042921-112837</ArticleId><ArticleId IdType="pubmed">36228171</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D., Liu J., Xiong H. NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes. Int. J. Physiol. Pathophysiol. Pharmacol. 2022;14:138&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301183</ArticleId><ArticleId IdType="pubmed">35891930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasool G., Riaz M., Abbas M., Fatima H., Qamar M.M., Zafar F., Mahmood Z. COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review. Int. J. Immunopathol. Pharmacol. 2022;36:3946320221115316. doi: 10.1177/03946320221115316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03946320221115316</ArticleId><ArticleId IdType="pmc">PMC9289644</ArticleId><ArticleId IdType="pubmed">35840546</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: Let patients help define long-lasting COVID symptoms. Nature. 2020;586:170. doi: 10.1038/d41586-020-02796-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J., Scorza F.A. Clinical and Pathophysiologic Spectrum of Neuro-COVID. Mol. Neurobiol. 2021;58:3787&#x2013;3791. doi: 10.1007/s12035-021-02383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02383-0</ArticleId><ArticleId IdType="pmc">PMC8026389</ArticleId><ArticleId IdType="pubmed">33829393</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies D.A., Adlimoghaddam A., Albensi B.C. The Effect of COVID-19 on NF-kappaB and Neurological Manifestations of Disease. Mol. Neurobiol. 2021;58:4178&#x2013;4187. doi: 10.1007/s12035-021-02438-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02438-2</ArticleId><ArticleId IdType="pmc">PMC8169418</ArticleId><ArticleId IdType="pubmed">34075562</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi M., Miar P., Norouzi S., Nikpour P. Nervous System Involvement in COVID-19: A Review of the Current Knowledge. Mol. Neurobiol. 2021;58:3561&#x2013;3574. doi: 10.1007/s12035-021-02347-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02347-4</ArticleId><ArticleId IdType="pubmed">33765290</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewanjee S., Vallamkondu J., Kalra R.S., Puvvada N., Kandimalla R., Reddy P.H. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic. Mol. Neurobiol. 2021;58:4694&#x2013;4715. doi: 10.1007/s12035-021-02450-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02450-6</ArticleId><ArticleId IdType="pmc">PMC8224263</ArticleId><ArticleId IdType="pubmed">34169443</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.A., Knauer M.J., Nicholson M., Daley M., Van Nynatten L.R., Martin C., Patterson E.K., Cepinskas G., Seney S.L., Dobretzberger V., et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol. Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T.M., Joca S., Wegener G., Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2014;A systematic review. Brain Behav. Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Vikse J., Omdal R. Fatigue in Mastocytosis: A Case Series. Clin. Ther. 2019;41:625&#x2013;632. doi: 10.1016/j.clinthera.2019.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.01.016</ArticleId><ArticleId IdType="pubmed">30797624</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgin-Lavialle S., Gaillard R., Moura D., Hermine O. Mastocytosis in adulthood and neuropsychiatric disorders. Transl. Res. 2016;174:77&#x2013;85.e71. doi: 10.1016/j.trsl.2016.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2016.03.013</ArticleId><ArticleId IdType="pubmed">27063957</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Pohlau D., Raithel M., Haenisch B., Dumoulin F.L., Homann J., Mauer U.M., Harzer S., Molderings G.J. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain Behav. Immun. 2015;50:314&#x2013;321. doi: 10.1016/j.bbi.2015.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.002</ArticleId><ArticleId IdType="pubmed">26162709</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziagelaki E., Adamaki M., Tsilioni I., Dimitriadis G., Theoharides T.C. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus? J. Pharmacol. Exp. Ther. 2018;367:155&#x2013;167. doi: 10.1124/jpet.118.250845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.250845</ArticleId><ArticleId IdType="pubmed">30076265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula S.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Amjad Kamal M., Staines D.R., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Thangavel R., Ahmed M.E., Zaheer S., Kumar K.K., Yelam A., Kaur H., Dubova I., Raikwar S.P., et al. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation. J. Alzheimers Dis. 2018;66:1117&#x2013;1129. doi: 10.3233/JAD-180786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180786</ArticleId><ArticleId IdType="pmc">PMC6334644</ArticleId><ArticleId IdType="pubmed">30372685</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Suzuki Y., Takemasa E., Watanabe R., Mogi M. Mast cells promote viral entry of SARS-CoV-2 via formation of chymase/spike protein complex. Eur. J. Pharmacol. 2022;930:175169. doi: 10.1016/j.ejphar.2022.175169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.175169</ArticleId><ArticleId IdType="pmc">PMC9339018</ArticleId><ArticleId IdType="pubmed">35921955</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S., Storan A., Myers B. Mast cell activation syndrome and the link with long COVID. Br. J. Hosp. Med. 2022;83:1&#x2013;10. doi: 10.12968/hmed.2022.0123.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType="pubmed">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdaca G., Di Gioacchino M., Greco M., Borro M., Paladin F., Petrarca C., Gangemi S. Basophils and Mast Cells in COVID-19 Pathogenesis. Cells. 2021;10:2754. doi: 10.3390/cells10102754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102754</ArticleId><ArticleId IdType="pmc">PMC8534912</ArticleId><ArticleId IdType="pubmed">34685733</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdemir O., Goksu Erol A.Y., Dikici U. Mast Cell&#x2019;s Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease. Curr. Pharm. Des. 2022;28:3261&#x2013;3268. doi: 10.2174/1381612829666221027114123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612829666221027114123</ArticleId><ArticleId IdType="pubmed">36305137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezi B., Chan L., Knapp J.P., Karimi N., Alizadeh K., Mehrani Y., Bridle B.W., Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells. 2021;10:1761. doi: 10.3390/cells10071761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071761</ArticleId><ArticleId IdType="pmc">PMC8308097</ArticleId><ArticleId IdType="pubmed">34359931</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S., Williams M.A. Confronting Our Next National Health Disaster&#x2014;Long-Haul Covid. N. Engl. J. Med. 2021;385:577&#x2013;579. doi: 10.1056/NEJMp2109285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacurci G., editor. Long Covid May Be &#x201c;The Next Public Health Disaster&#x201d;&#x2014;With a $3.7 Trillion Economic Impact Rivaline the Great Recession. CNBC; Englewood Cliffs, NJ, USA: 2022. Your Health, Your Money.</Citation></Reference><Reference><Citation>Tremblay M.E., Madore C., Bordeleau M., Tian L., Verkhratsky A. Neuropathobiology of COVID-19: The Role for Glia. Front. Cell. Neurosci. 2020;14:592214. doi: 10.3389/fncel.2020.592214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.592214</ArticleId><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon C.L., Staples H., Gazi M., Carrion R., Hsieh J. SARS-CoV-2 targets glial cells in human cortical organoids. Stem Cell Rep. 2021;16:1156&#x2013;1164. doi: 10.1016/j.stemcr.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC8111796</ArticleId><ArticleId IdType="pubmed">33979600</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., von Bartheld C.S. The route of SARS-CoV-2 to brain infection: Have we been barking up the wrong tree? Mol. Neurodegener. 2022;17:20. doi: 10.1186/s13024-022-00529-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00529-9</ArticleId><ArticleId IdType="pmc">PMC8922388</ArticleId><ArticleId IdType="pubmed">35292068</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol. Immunol. 2020;17:613&#x2013;620. doi: 10.1038/s41423-020-0400-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0400-4</ArticleId><ArticleId IdType="pmc">PMC7091888</ArticleId><ArticleId IdType="pubmed">32203189</ArticleId></ArticleIdList></Reference><Reference><Citation>Espindola O.M., Gomes Y.C.P., Brandao C.O., Torres R.C., Siqueira M., Soares C.N., Lima M., Leite A., Venturotti C.O., Carvalho A.J.C., et al. Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019. Ann. Neurol. 2021;89:1041&#x2013;1045. doi: 10.1002/ana.26041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26041</ArticleId><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka Y., Ueda A., Nakagawa T., Kikuchi Y., Inoue D., Marumo S., Matsumoto S. SARS-CoV-2-related Progressive Brain White Matter Lesion Associated with an Increased Cerebrospinal Fluid Level of IL-6. Intern. Med. 2021;60:3167&#x2013;3170. doi: 10.2169/internalmedicine.8123-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.8123-21</ArticleId><ArticleId IdType="pmc">PMC8545645</ArticleId><ArticleId IdType="pubmed">34373382</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Brunink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao L., Yang Y., Yu W., Zhao Y., Long H., Gao J., Ding K., Ma C., Li J., Zhao S., et al. The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal Transduct. Target. Ther. 2021;6:169. doi: 10.1038/s41392-021-00591-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00591-7</ArticleId><ArticleId IdType="pmc">PMC8065334</ArticleId><ArticleId IdType="pubmed">33895780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes I., Karmirian K., Oliveira J.T., Pedrosa C., Mendes M.A., Rosman F.C., Chimelli L., Rehen S. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy. Lancet Reg. Health Am. 2021;2:100046. doi: 10.1016/j.lana.2021.100046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100046</ArticleId><ArticleId IdType="pmc">PMC8397543</ArticleId><ArticleId IdType="pubmed">34485969</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B., Chance R., Macaulay I.C., Chou H.J., Fletcher R.B., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6:eabc5801. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhong S., Liu J., Li L., Li Y., Wu X., Li Z., Deng P., Zhang J., Zhong N., et al. Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 2005;41:1089&#x2013;1096. doi: 10.1086/444461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/444461</ArticleId><ArticleId IdType="pmc">PMC7107994</ArticleId><ArticleId IdType="pubmed">16163626</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnik M., Beeraka N.M., Uthaiah C.A., Nataraj S.M., Bettadapura A.D.S., Aliev G., Madhunapantula S.V. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Mol. Neurobiol. 2021;58:4535&#x2013;4563. doi: 10.1007/s12035-021-02399-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02399-6</ArticleId><ArticleId IdType="pmc">PMC8179092</ArticleId><ArticleId IdType="pubmed">34089508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodagar A., Javed R., Tahir H., Razak S.I.A., Shakir M., Naeem M., Yusof A.H.A., Sagadevan S., Hazafa A., Uddin J., et al. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules. 2022;12:971. doi: 10.3390/biom12070971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070971</ArticleId><ArticleId IdType="pmc">PMC9313047</ArticleId><ArticleId IdType="pubmed">35883527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M.E., Madore C., Tian L., Verkhratsky A. Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19. Front. Cell. Neurosci. 2022;16:840121. doi: 10.3389/fncel.2022.840121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.840121</ArticleId><ArticleId IdType="pmc">PMC8863733</ArticleId><ArticleId IdType="pubmed">35221927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular Injury in the Brains of Patients with COVID-19. N. Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Adesse D., Gladulich L., Alvarez-Rosa L., Siqueira M., Marcos A.C., Heider M., Motta C.S., Torices S., Toborek M., Stipursky J. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: Impacts on neurological symptoms of COVID-19. Fluids Barriers CNS. 2022;19:63. doi: 10.1186/s12987-022-00357-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00357-5</ArticleId><ArticleId IdType="pmc">PMC9386676</ArticleId><ArticleId IdType="pubmed">35982454</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodnar B., Patel K., Ho W., Luo J.J., Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J. Med. Virol. 2021;93:1983&#x2013;1998. doi: 10.1002/jmv.26720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26720</ArticleId><ArticleId IdType="pmc">PMC7897247</ArticleId><ArticleId IdType="pubmed">33300152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng J.H., Sun A., Je H.S., Tan E.K. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids. Neuroscientist. 2021;29:30&#x2013;40. doi: 10.1177/10738584211015136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10738584211015136</ArticleId><ArticleId IdType="pmc">PMC9902967</ArticleId><ArticleId IdType="pubmed">34036855</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp. Brain Res. 2022;240:9&#x2013;25. doi: 10.1007/s00221-021-06244-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-021-06244-z</ArticleId><ArticleId IdType="pmc">PMC8543422</ArticleId><ArticleId IdType="pubmed">34694467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Zhang J., Xiao T., Peng H., Sterling S.M., Walsh R.M., Jr., Rawson S., Rits-Volloch S., Chen B. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586&#x2013;1592. doi: 10.1126/science.abd4251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4251</ArticleId><ArticleId IdType="pmc">PMC7464562</ArticleId><ArticleId IdType="pubmed">32694201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong G.U., Lyu J., Kim K.D., Chung Y.C., Yoon G.Y., Lee S., Hwang I., Shin W.H., Ko J., Lee J.Y., et al. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiol. Spectr. 2022;10:e0109122. doi: 10.1128/spectrum.01091-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01091-22</ArticleId><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide O.A., Iwuanyanwu V.U., Adegbola O.D., Al-Hindawi A.A. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia. Mol. Neurobiol. 2022;59:445&#x2013;458. doi: 10.1007/s12035-021-02593-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02593-6</ArticleId><ArticleId IdType="pmc">PMC8551352</ArticleId><ArticleId IdType="pubmed">34709564</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudyata, Oliveira A.O., Malwade S., Rufino de Sousa N., Goparaju S.K., Gracias J., Orhan F., Steponaviciute L., Schalling M., Sheridan S.D., et al. SARS-CoV-2 promotes microglial synapse elimination in human brain organoids. Mol. Psychiatry. 2022;27:3939&#x2013;3950. doi: 10.1038/s41380-022-01786-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9533278</ArticleId><ArticleId IdType="pubmed">36198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M.G., Nguyen K.H., Ball J.B., Hopkins S., Kelley T., Baratta M.V., Fleshner M., Maier S.F. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties. Brain Behav. Immun. 2022;100:267&#x2013;277. doi: 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieff M.G., Feldman E.L., Stino A.M. Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection. Neurobiol. Dis. 2022;168:105715. doi: 10.1016/j.nbd.2022.105715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105715</ArticleId><ArticleId IdType="pmc">PMC8963977</ArticleId><ArticleId IdType="pubmed">35364273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Jeon M.T., Kim K.S., Lee S., Kim S., Kim D.G. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells. Viruses. 2021;13:2021. doi: 10.3390/v13102021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102021</ArticleId><ArticleId IdType="pmc">PMC8538996</ArticleId><ArticleId IdType="pubmed">34696455</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Morigi M., Galbusera M., Pezzotta A., Gastoldi S., Imberti B., Perna A., Ruggenenti P., Donadelli R., Benigni A., et al. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front. Immunol. 2022;13:827146. doi: 10.3389/fimmu.2022.827146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.827146</ArticleId><ArticleId IdType="pmc">PMC8936079</ArticleId><ArticleId IdType="pubmed">35320941</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S., Leo M.D. Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells. Front. Pharmacol. 2022;13:872736. doi: 10.3389/fphar.2022.872736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.872736</ArticleId><ArticleId IdType="pmc">PMC9084361</ArticleId><ArticleId IdType="pubmed">35548336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.C., Huang K., Zhang H.P., Li L., Zhang Y.F., Tan C., Chen H.C., Jin M.L., Wang X.R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflamm. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Rhea E.M., Knopp R.C., Banks W.A. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int. J. Mol. Sci. 2021;22:2681. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>DeOre B.J., Tran K.A., Andrews A.M., Ramirez S.H., Galie P.A. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation. J. Neuroimmune Pharmacol. 2021;16:722&#x2013;728. doi: 10.1007/s11481-021-10029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10029-0</ArticleId><ArticleId IdType="pmc">PMC8536479</ArticleId><ArticleId IdType="pubmed">34687399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nation D.A., Sweeney M.D., Montagne A., Sagare A.P., D&#x2019;Orazio L.M., Pachicano M., Sepehrband F., Nelson A.R., Buennagel D.P., Harrington M.G., et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat. Med. 2019;25:270&#x2013;276. doi: 10.1038/s41591-018-0297-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0297-y</ArticleId><ArticleId IdType="pmc">PMC6367058</ArticleId><ArticleId IdType="pubmed">30643288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;320. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovszki D., Walter F.R., Vigh J.P., Kocsis A., Valkai S., Deli M.A., Der A. Penetration of the SARS-CoV-2 Spike Protein across the Blood-Brain Barrier, as Revealed by a Combination of a Human Cell Culture Model System and Optical Biosensing. Biomedicines. 2022;10:188. doi: 10.3390/biomedicines10010188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10010188</ArticleId><ArticleId IdType="pmc">PMC8773803</ArticleId><ArticleId IdType="pubmed">35052867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C., Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Zhao H., Fang D., Davis C.T., Shi D.S., Lei K., Rich B.E., Winter J.M., Guo L., Sorensen L.K., et al. Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling. Neuron. 2022;110:3106&#x2013;3120.e3107. doi: 10.1016/j.neuron.2022.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.07.015</ArticleId><ArticleId IdType="pmc">PMC9547934</ArticleId><ArticleId IdType="pubmed">35961320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wierzba-Bobrowicz T., Krajewski P., Tarka S., Acewicz A., Felczak P., Stepien T., Golan M.P., Grzegorczyk M. Neuropathological analysis of the brains of fifty-two patients with COVID-19. Folia Neuropathol. 2021;59:219&#x2013;231. doi: 10.5114/fn.2021.108829.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2021.108829</ArticleId><ArticleId IdType="pubmed">34628787</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., Possnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., Muller J., Chiappini A., Rychen J., et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: A prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumont H., Kaczorowski F., San-Galli A., Michel P.P., Tressieres B., Roze E., Quadrio I., Lannuzel A. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes. Rev. Neurol. 2022 doi: 10.1016/j.neurol.2022.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2022.11.002</ArticleId><ArticleId IdType="pmc">PMC9708608</ArticleId><ArticleId IdType="pubmed">36610823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira de Araujo J.L., Menezes D., Saraiva-Duarte J.M., de Lima Ferreira L., Santana de Aguiar R., Pedra de Souza R. Systematic review of host genetic association with COVID-19 prognosis and susceptibility: What have we learned in 2020? Rev. Med. Virol. 2022;32:e2283. doi: 10.1002/rmv.2283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2283</ArticleId><ArticleId IdType="pmc">PMC8420453</ArticleId><ArticleId IdType="pubmed">34338380</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkouskou K., Vasilogiannakopoulou T., Andreakos E., Davanos N., Gazouli M., Sanoudou D., Eliopoulos A.G. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox. Biol. 2021;41:101938. doi: 10.1016/j.redox.2021.101938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101938</ArticleId><ArticleId IdType="pmc">PMC7943392</ArticleId><ArticleId IdType="pubmed">33730676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz G.G., Velazquez-Brizuela I.E., Ortiz-Velazquez G.E., Ocampo-Alfaro M.J., Salazar-Flores J., Delgado-Lara D.L.C., Torres-Sanchez E.D. Alzheimer&#x2019;s Disease and SARS-CoV-2: Pathophysiological Analysis and Social Context. Brain Sci. 2022;12:1405. doi: 10.3390/brainsci12101405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12101405</ArticleId><ArticleId IdType="pmc">PMC9599687</ArticleId><ArticleId IdType="pubmed">36291338</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein M.R., Poland G.A., Graeber A.C.W. Does apolipoprotein E genotype predict COVID-19 severity? QJM. 2020;113:529&#x2013;530. doi: 10.1093/qjmed/hcaa142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa142</ArticleId><ArticleId IdType="pmc">PMC7197574</ArticleId><ArticleId IdType="pubmed">32339247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K., Kaur G., Pathak T., Banerjee I. Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity. Gene. 2022;844:146790. doi: 10.1016/j.gene.2022.146790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2022.146790</ArticleId><ArticleId IdType="pmc">PMC9384365</ArticleId><ArticleId IdType="pubmed">35987511</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Nation D.A., Sagare A.P., Barisano G., Sweeney M.D., Chakhoyan A., Pachicano M., Joe E., Nelson A.R., D&#x2019;Orazio L.M., et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71&#x2013;76. doi: 10.1038/s41586-020-2247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2247-3</ArticleId><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Onofrio L., Caraglia M., Facchini G., Margherita V., Placido S., Buonerba C. Toll-like receptors and COVID-19: A two-faced story with an exciting ending. Future Sci. OA. 2020;6:FSO605. doi: 10.2144/fsoa-2020-0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/fsoa-2020-0091</ArticleId><ArticleId IdType="pmc">PMC7434222</ArticleId><ArticleId IdType="pubmed">32974046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sariol A., Perlman S. SARS-CoV-2 takes its Toll. Nat. Immunol. 2021;22:801&#x2013;802. doi: 10.1038/s41590-021-00962-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00962-w</ArticleId><ArticleId IdType="pmc">PMC8238877</ArticleId><ArticleId IdType="pubmed">34103714</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H., Singh A., Khan A.A., Gupta V. Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease. Microb. Pathog. 2021;158:105023. doi: 10.1016/j.micpath.2021.105023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105023</ArticleId><ArticleId IdType="pmc">PMC8177310</ArticleId><ArticleId IdType="pubmed">34090983</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanmohammadi S., Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19. J. Med. Virol. 2021;93:2735&#x2013;2739. doi: 10.1002/jmv.26826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26826</ArticleId><ArticleId IdType="pmc">PMC8014260</ArticleId><ArticleId IdType="pubmed">33506952</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005;175:4320&#x2013;4330. doi: 10.4049/jimmunol.175.7.4320.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.7.4320</ArticleId><ArticleId IdType="pubmed">16177072</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas G., Medeiros Geraldo L.H., Gedeao Salomao N., Viana Paes M., Regina Souza Lima F., Carvalho Alcantara Gomes F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives. Brain Behav. Immun. Health. 2020;7:100127. doi: 10.1016/j.bbih.2020.100127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100127</ArticleId><ArticleId IdType="pmc">PMC7423575</ArticleId><ArticleId IdType="pubmed">32838339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Karki R., Williams E.P., Yang D., Fitzpatrick E., Vogel P., Jonsson C.B., Kanneganti T.D. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 2021;22:829&#x2013;838. doi: 10.1038/s41590-021-00937-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya M.M., Heads R.J. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediat. Inflamm. 2021;2021:8874339. doi: 10.1155/2021/8874339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Manan A., Pirzada R.H., Haseeb M., Choi S. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. Int. J. Mol. Sci. 2022;23:10716. doi: 10.3390/ijms231810716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810716</ArticleId><ArticleId IdType="pmc">PMC9502216</ArticleId><ArticleId IdType="pubmed">36142620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik D., Bhandari R., Kuhad A. TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2. Expert Opin. Ther. Targets. 2021;25:491&#x2013;508. doi: 10.1080/14728222.2021.1918103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2021.1918103</ArticleId><ArticleId IdType="pmc">PMC8095161</ArticleId><ArticleId IdType="pubmed">33857397</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilioni I., Theoharides T.C. Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells. Res. Sq. 2023 doi: 10.21203/rs.3.rs-2394904/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2394904/v1</ArticleId><ArticleId IdType="pubmed">37477768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos S.E., Medeiros M., Porfirio J., Tavares W., Pessoa L., Grinberg L., Leite R.E.P., Ferretti-Rebustini R.E.L., Suemoto C.K., Filho W.J., et al. Similar Microglial Cell Densities across Brain Structures and Mammalian Species: Implications for Brain Tissue Function. J. Neurosci. 2020;40:4622&#x2013;4643. doi: 10.1523/JNEUROSCI.2339-19.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2339-19.2020</ArticleId><ArticleId IdType="pmc">PMC7294795</ArticleId><ArticleId IdType="pubmed">32253358</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M., Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 2017;35:441&#x2013;468. doi: 10.1146/annurev-immunol-051116-052358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 2010;6:193&#x2013;201. doi: 10.1038/nrneurol.2010.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.17</ArticleId><ArticleId IdType="pubmed">20234358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777&#x2013;783. doi: 10.1126/science.aag2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova D.M., Brown D.R. Microglia and the aging brain: Are senescent microglia the key to neurodegeneration? J. Neurochem. 2019;151:676&#x2013;688. doi: 10.1111/jnc.14860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14860</ArticleId><ArticleId IdType="pubmed">31478208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S., Jimenez-Ferrer I., Paulus A., Yang Y., Swanberg M., Deierborg T., Boza-Serrano A. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front. Cell. Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00488</ArticleId><ArticleId IdType="pmc">PMC6305407</ArticleId><ArticleId IdType="pubmed">30618635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S., Izzy S., Sen P., Morsett L., El K.J. Microglia in neurodegeneration. Nat. Neurosci. 2018;21:1359&#x2013;1369. doi: 10.1038/s41593-018-0242-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0242-x</ArticleId><ArticleId IdType="pmc">PMC6817969</ArticleId><ArticleId IdType="pubmed">30258234</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberman A.C., Trias E., da Silva C.L., Trindade P., Dos Santos P.M., Refojo D., Hedin-Pereira C., Serfaty C.A. Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System. Neuroimmunomodulation. 2018;25:246&#x2013;270. doi: 10.1159/000494761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000494761</ArticleId><ArticleId IdType="pubmed">30517945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., He D., Bai Y. Microglia-Mediated Inflammation and Neurodegenerative Disease. Mol. Neurobiol. 2016;53:6709&#x2013;6715. doi: 10.1007/s12035-015-9593-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9593-4</ArticleId><ArticleId IdType="pubmed">26659872</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhramanyam C.S., Wang C., Hu Q., Dheen S.T. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin. Cell Dev. Biol. 2019;94:112&#x2013;120. doi: 10.1016/j.semcdb.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.004</ArticleId><ArticleId IdType="pubmed">31077796</ArticleId></ArticleIdList></Reference><Reference><Citation>Voet S., Prinz M., van Loo G. Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology. Trends Mol. Med. 2019;25:112&#x2013;123. doi: 10.1016/j.molmed.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.11.005</ArticleId><ArticleId IdType="pubmed">30578090</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves de Andrade E., Simoncicova E., Carrier M., Vecchiarelli H.A., Robert M.E., Tremblay M.E. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic. Front. Cell. Neurosci. 2021;15:647378. doi: 10.3389/fncel.2021.647378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.647378</ArticleId><ArticleId IdType="pmc">PMC7961561</ArticleId><ArticleId IdType="pubmed">33737867</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Salie H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., Mayer L., Matschke J., Puschel K., Fitzek A., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610.e1511. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni T.E., Medici V., Moretti M., Visona S.D., Cirrincione A., Carlos A.F., Davin A., Gagliardi S., Pansarasa O., Cereda C., et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol. 2021;31:e12997. doi: 10.1111/bpa.12997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12997</ArticleId><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni T.E., Moretti M., Medici V., Turturici E., Belli G., Cavriani E., Visona S.D., Rossi M., Fantini V., Ferrari R.R., et al. COVID-19 Pathology in the Lung, Kidney, Heart and Brain: The Different Roles of T-Cells, Macrophages, and Microthrombosis. Cells. 2022;11:3124. doi: 10.3390/cells11193124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11193124</ArticleId><ArticleId IdType="pmc">PMC9563269</ArticleId><ArticleId IdType="pubmed">36231087</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai S.N., Tiwari N., Singh P., Singh A.K., Mishra D., Imran M., Singh S., Hooshmandi E., Vamanu E., Singh S.K., et al. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson&#x2019;s and Alzheimer&#x2019;s Disease. Oxid. Med. Cell. Longev. 2022;2022:3012778. doi: 10.1155/2022/3012778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3012778</ArticleId><ArticleId IdType="pmc">PMC9453010</ArticleId><ArticleId IdType="pubmed">36092161</ArticleId></ArticleIdList></Reference><Reference><Citation>Baazaoui N., Iqbal K. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. J. Alzheimers Dis. 2022;88:399&#x2013;416. doi: 10.3233/JAD-220105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220105</ArticleId><ArticleId IdType="pubmed">35599487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y.W., Xu H.S., Liu S.J. COVID-19 and neurodegenerative diseases. Eur. Rev. Med. Pharmacol. Sci. 2022;26:4535&#x2013;4544. doi: 10.26355/eurrev_202206_29093.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202206_29093</ArticleId><ArticleId IdType="pubmed">35776055</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Todorov V., Kanczkowski W., Eisenhofer G., Schedl A., Wong M.L., Licinio J., Bauer M., Young A.H., Gainetdinov R.R., et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol. Psychiatry. 2020;25:1611&#x2013;1617. doi: 10.1038/s41380-020-0758-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0758-9</ArticleId><ArticleId IdType="pmc">PMC7204611</ArticleId><ArticleId IdType="pubmed">32382135</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. The impact of psychological stress on mast cells. Ann. Allergy Asthma Immunol. 2020;125:388&#x2013;392. doi: 10.1016/j.anai.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.07.007</ArticleId><ArticleId IdType="pubmed">32687989</ArticleId></ArticleIdList></Reference><Reference><Citation>Manchia M., Gathier A.W., Yapici-Eser H., Schmidt M.V., de Quervain D., van Amelsvoort T., Bisson J.I., Cryan J.F., Howes O.D., Pinto L., et al. The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. Eur. Neuropsychopharmacol. 2022;55:22&#x2013;83. doi: 10.1016/j.euroneuro.2021.10.864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.10.864</ArticleId><ArticleId IdType="pmc">PMC8554139</ArticleId><ArticleId IdType="pubmed">34818601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindert J., Jakubauskiene M., Bilsen J. The COVID-19 disaster and mental health-assessing, responding and recovering. Eur. J. Public Health. 2021;31((Suppl. 4)):iv31&#x2013;iv35. doi: 10.1093/eurpub/ckab153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckab153</ArticleId><ArticleId IdType="pmc">PMC8576295</ArticleId><ArticleId IdType="pubmed">34751367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkstra A., Elbert S.P. Detecting and Preventing Defensive Reactions Toward Persuasive Information on Fruit and Vegetable Consumption Using Induced Eye Movements. Front. Psychol. 2020;11:578287. doi: 10.3389/fpsyg.2020.578287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.578287</ArticleId><ArticleId IdType="pmc">PMC7829457</ArticleId><ArticleId IdType="pubmed">33505330</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra R., Das N.C., Mukherjee S. Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective. Adv. Exp. Med. Biol. 2021;1352:87&#x2013;109. doi: 10.1007/978-3-030-85109-5_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-85109-5_6</ArticleId><ArticleId IdType="pubmed">35132596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallach T., Raden M., Hinkelmann L., Brehm M., Rabsch D., Weidling H., Kruger C., Kettenmann H., Backofen R., Lehnardt S. Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Front. Immunol. 2022;13:1066456. doi: 10.3389/fimmu.2022.1066456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1066456</ArticleId><ArticleId IdType="pmc">PMC9880480</ArticleId><ArticleId IdType="pubmed">36713399</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Dicou E., Vincent J.P., Mazella J. Neurotensin and the neurotensin receptor-3 in microglial cells. J. Neurosci. Res. 2005;81:322&#x2013;326. doi: 10.1002/jnr.20477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20477</ArticleId><ArticleId IdType="pubmed">15957186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Ji P., Riopelle R.J., Dow K.E. Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia. J. Neurochem. 2002;80:287&#x2013;294. doi: 10.1046/j.0022-3042.2001.00687.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00687.x</ArticleId><ArticleId IdType="pubmed">11902119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Ahmed M.E., Raikwar S.P., Thangavel R., Khan A., Zaheer S.A., Iyer S.S., Burton C., James D., et al. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. Neuroscientist. 2020;26:402&#x2013;414. doi: 10.1177/1073858420941476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420941476</ArticleId><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A.B., Tsilioni I., Leeman S.E., Theoharides T.C. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. Proc. Natl. Acad. Sci. USA. 2016;113:E7049&#x2013;E7058. doi: 10.1073/pnas.1604992113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604992113</ArticleId><ArticleId IdType="pmc">PMC5111711</ArticleId><ArticleId IdType="pubmed">27663735</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraula A., Sheridan J.F., Godbout J.P. Microglia Priming with Aging and Stress. Neuropsychopharmacology. 2016;42:318&#x2013;333. doi: 10.1038/npp.2016.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2016.185</ArticleId><ArticleId IdType="pmc">PMC5143497</ArticleId><ArticleId IdType="pubmed">27604565</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M., Simoncicova E., St-Pierre M.K., McKee C., Tremblay M.E. Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk. Front. Mol. Neurosci. 2021;14:749737. doi: 10.3389/fnmol.2021.749737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.749737</ArticleId><ArticleId IdType="pmc">PMC8599581</ArticleId><ArticleId IdType="pubmed">34803607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimian R., Wakid M., O&#x2019;Leary L.A., Mechawar N. The emerging tale of microglia in psychiatric disorders. Neurosci. Biobehav. Rev. 2021;131:1&#x2013;29. doi: 10.1016/j.neubiorev.2021.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.09.023</ArticleId><ArticleId IdType="pubmed">34536460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohleb E.S. Neuron-Microglia Interactions in Mental Health Disorders: &#x201c;For Better, and For Worse&#x201d;. Front. Immunol. 2016;7:544. doi: 10.3389/fimmu.2016.00544.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00544</ArticleId><ArticleId IdType="pmc">PMC5126117</ArticleId><ArticleId IdType="pubmed">27965671</ArticleId></ArticleIdList></Reference><Reference><Citation>Troubat R., Barone P., Leman S., Desmidt T., Cressant A., Atanasova B., Brizard B., El Hage W., Surget A., Belzung C., et al. Neuroinflammation and depression: A review. Eur. J. Neurosci. 2021;53:151&#x2013;171. doi: 10.1111/ejn.14720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14720</ArticleId><ArticleId IdType="pubmed">32150310</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Fernandes A. Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Front. Cell. Neurosci. 2015;9:476. doi: 10.3389/fncel.2015.00476.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00476</ArticleId><ArticleId IdType="pmc">PMC4681811</ArticleId><ArticleId IdType="pubmed">26733805</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Jr., Steardo L., Verkhratsky A. Psychiatric face of COVID-19. Transl. Psychiatry. 2020;10:261. doi: 10.1038/s41398-020-00949-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-00949-5</ArticleId><ArticleId IdType="pmc">PMC7391235</ArticleId><ArticleId IdType="pubmed">32732883</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L., Varley J., Gontsarova A., Mallon D., Tona F., Muir D., Luqmani A., Jenkins I.H., Nicholas R., Jones B., et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e789. doi: 10.1212/NXI.0000000000000789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000789</ArticleId><ArticleId IdType="pmc">PMC7286661</ArticleId><ArticleId IdType="pubmed">32457227</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni M.E., Simani L., Bluyssen H.A.R., Samadikhah H.R., Zamanlui Benisi S., Hassani S., Akbari Dilmaghani N., Fathi M., Vakili K., Mahmoudiasl G.R., et al. Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem. Neurosci. 2021;12:2143&#x2013;2150. doi: 10.1021/acschemneuro.1c00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00111</ArticleId><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.B., Logue J., Yang P., Baracco L., Elahi M., Reece E.A., Wang B., Li L., Blanchard T.G., Han Z., et al. SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer&#x2019;s-like neuropathology. bioRxiv. 2022 doi: 10.1101/2022.01.31.478476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.31.478476</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan R.K., Kandasamy M. SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia. Am. J. Alzheimers Dis. Other Demen. 2022;37:15333175221078418. doi: 10.1177/15333175221078418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15333175221078418</ArticleId><ArticleId IdType="pmc">PMC10581113</ArticleId><ArticleId IdType="pubmed">35133907</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:939&#x2013;963. doi: 10.1007/s10787-021-00806-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C.M., Mulvey J., Kubiak J., Mikhail S., Suster D., Crowson A.N., Laurence J., Nuovo G. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann. Diagn. Pathol. 2021;50:151645. doi: 10.1016/j.anndiagpath.2020.151645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151645</ArticleId><ArticleId IdType="pmc">PMC7553104</ArticleId><ArticleId IdType="pubmed">33248385</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Consortium C.-G.U., et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021;19:409&#x2013;424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriksen E., van Bergeijk D., Oosting R.S., Redegeld F.A. Mast cells in neuroinflammation and brain disorders. Neurosci. Biobehav. Rev. 2017;79:119&#x2013;133. doi: 10.1016/j.neubiorev.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.05.001</ArticleId><ArticleId IdType="pubmed">28499503</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Facci L., Zusso M., Giusti P. Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons. Neuroscientist. 2017;23:478&#x2013;498. doi: 10.1177/1073858416687249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858416687249</ArticleId><ArticleId IdType="pubmed">29283023</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang Y., Dong H., Xu Y., Zhang S. Induction of Microglial Activation by Mediators Released from Mast Cells. Cell. Physiol. Biochem. 2016;38:1520&#x2013;1531. doi: 10.1159/000443093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443093</ArticleId><ArticleId IdType="pubmed">27050634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Zaheer S., Thangavel R., Ahmed M.E., Raikwar S., Govindarajan R., Iyer S., Zaheer A. Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson&#x2019;s Disease. J. Neuroimmune Pharmacol. 2018;13:100&#x2013;112. doi: 10.1007/s11481-017-9766-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-017-9766-1</ArticleId><ArticleId IdType="pmc">PMC5802395</ArticleId><ArticleId IdType="pubmed">28952015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Zhang X., Wang Y., Zhou X., Qian Y., Zhang S. Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation. Mol. Neurobiol. 2017;54:997&#x2013;1007. doi: 10.1007/s12035-016-9720-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9720-x</ArticleId><ArticleId IdType="pubmed">26797518</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar G.P., Ahmed M.E., Thangavel R., Kempuraj D., Dubova I., Raikwar S.P., Zaheer S., Iyer S.S., Zaheer A. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice. Brain Behav. Immun. 2020;87:429&#x2013;443. doi: 10.1016/j.bbi.2020.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.01.013</ArticleId><ArticleId IdType="pmc">PMC7316620</ArticleId><ArticleId IdType="pubmed">31982500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Thangavel R., Selvakumar G.P., Ahmed M.E., Zaheer S., Raikwar S.P., Zahoor H., Saeed D., Dubova I., Giler G., et al. Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-kappaB. Mol. Neurobiol. 2019;56:1681&#x2013;1693. doi: 10.1007/s12035-018-1177-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1177-7</ArticleId><ArticleId IdType="pmc">PMC6298852</ArticleId><ArticleId IdType="pubmed">29916143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Wang Y., Zhang X., Zhang X., Qian Y., Ding H., Zhang S. Stabilization of Brain Mast Cells Alleviates LPS-Induced Neuroinflammation by Inhibiting Microglia Activation. Front. Cell. Neurosci. 2019;13:191. doi: 10.3389/fncel.2019.00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00191</ArticleId><ArticleId IdType="pmc">PMC6509474</ArticleId><ArticleId IdType="pubmed">31130850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Sha H., Zhou L., Chen Y., Zhou Q., Dong H., Qian Y. The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus. Mediat. Inflamm. 2020;2020:8098439. doi: 10.1155/2020/8098439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8098439</ArticleId><ArticleId IdType="pmc">PMC7060448</ArticleId><ArticleId IdType="pubmed">32184702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Dong H., Li N., Zhang S., Sun J., Zhang S., Qian Y. Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis 1. J. Neuroinflamm. 2016;13:127. doi: 10.1186/s12974-016-0592-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0592-9</ArticleId><ArticleId IdType="pmc">PMC4888609</ArticleId><ArticleId IdType="pubmed">27245661</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugajski A.J., Chlap Z., Gadek-Michalska A., Borycz J., Bugajski J. Degranulation and decrease in histamine levels of thalamic mast cells coincides with corticosterone secretion induced by compound 48/80. Inflamm. Res. 1995;44((Suppl. 1)):S50&#x2013;S51. doi: 10.1007/BF01674391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01674391</ArticleId><ArticleId IdType="pubmed">8520998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalogeromitros D., Syrigou E.I., Makris M., Kempuraj D., Stavrianeas N.G., Vasiadi M., Theoharides T.C. Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Ann. Allergy Asthma Immunol. 2007;98:269&#x2013;273. doi: 10.1016/S1081-1206(10)60717-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)60717-X</ArticleId><ArticleId IdType="pubmed">17378259</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto I., Inoue Y., Shimada T., Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J. Exp. Med. 2001;194:71&#x2013;78. doi: 10.1084/jem.194.1.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.194.1.71</ArticleId><ArticleId IdType="pmc">PMC2193441</ArticleId><ArticleId IdType="pubmed">11435473</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Donelan J.M., Papadopoulou N., Cao J., Kempuraj D., Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 2004;25:563&#x2013;568. doi: 10.1016/j.tips.2004.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2004.09.007</ArticleId><ArticleId IdType="pubmed">15491778</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaccianoce S., Lombardo K., Nicolai R., Affricano D., Angelucci L. Studies on the involvement of histamine in the hypothalamic-pituitary-adrenal axis activation induced by nerve growth factor. Life Sci. 2000;67:3143&#x2013;3152. doi: 10.1016/S0024-3205(00)00899-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(00)00899-7</ArticleId><ArticleId IdType="pubmed">11191621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 1993;77:1690&#x2013;1694.</Citation><ArticleIdList><ArticleId IdType="pubmed">8263159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Papadopoulou N.G., Lytinas M., Huang M., Kandere-Grzybowska K., Madhappan B., Boucher W., Christodoulou S., Athanassiou A., Theoharides T.C. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology. 2004;145:43&#x2013;48. doi: 10.1210/en.2003-0805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2003-0805</ArticleId><ArticleId IdType="pubmed">14576187</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan A.A., Porter T., Quek H., White A., Haynes J., Jackaman C., Villemagne V., Munyard K., Laws S.M., Verdile G., et al. Chronic stress and Alzheimer&#x2019;s disease: The interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia. Biol. Rev. Camb. Philos. Soc. 2021;96:2209&#x2013;2228. doi: 10.1111/brv.12750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12750</ArticleId><ArticleId IdType="pubmed">34159699</ArticleId></ArticleIdList></Reference><Reference><Citation>Alysandratos K.D., Asadi S., Angelidou A., Zhang B., Sismanopoulos N., Yang H., Critchfield A., Theoharides T.C. Neurotensin and CRH interactions augment human mast cell activation. PLoS ONE. 2012;7:e48934. doi: 10.1371/journal.pone.0048934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048934</ArticleId><ArticleId IdType="pmc">PMC3498358</ArticleId><ArticleId IdType="pubmed">23155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Mentor S., Thangavel R., Ahmed M.E., Selvakumar G.P., Raikwar S.P., Dubova I., Zaheer S., Iyer S.S., Zaheer A. Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2019;13:54. doi: 10.3389/fncel.2019.00054.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00054</ArticleId><ArticleId IdType="pmc">PMC6389675</ArticleId><ArticleId IdType="pubmed">30837843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Zhang X., Zhang Y., Qu C., Zhou X., Zhang S. Histamine Induces Microglia Activation and the Release of Proinflammatory Mediators in Rat Brain Via H1R or H4R. J. Neuroimmune Pharmacol. 2020;15:280&#x2013;291. doi: 10.1007/s11481-019-09887-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-019-09887-6</ArticleId><ArticleId IdType="pubmed">31863333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zeng X., Yang H., Hu G., He S. Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell. Physiol. Biochem. 2012;29:931&#x2013;940. doi: 10.1159/000171029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000171029</ArticleId><ArticleId IdType="pubmed">22613992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Chen L., Li X., Li T., Dong Z., Wang Y.T. Food allergy induces alteration in brain inflammatory status and cognitive impairments. Behav. Brain Res. 2019;364:374&#x2013;382. doi: 10.1016/j.bbr.2018.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2018.01.011</ArticleId><ArticleId IdType="pubmed">29339006</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain J.L., Mazzotta E.A., Maradiaga N., Duque-Wilckens N., Grants I., Robison A.J., Christofi F.L., Moeser A.J., Gulbransen B.D. Histamine-dependent interactions between mast cells, glia, and neurons are altered following early-life adversity in mice and humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2020;319:G655&#x2013;G668. doi: 10.1152/ajpgi.00041.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00041.2020</ArticleId><ArticleId IdType="pmc">PMC7792668</ArticleId><ArticleId IdType="pubmed">32996781</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature. 2008;454:445&#x2013;454. doi: 10.1038/nature07204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07204</ArticleId><ArticleId IdType="pmc">PMC3573758</ArticleId><ArticleId IdType="pubmed">18650915</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Alysandratos K.D., Angelidou A., Delivanis D.A., Sismanopoulos N., Zhang B., Asadi S., Vasiadi M., Weng Z., Miniati A., et al. Mast cells and inflammation. Biochim. Biophys. Acta. 2012;1822:21&#x2013;33. doi: 10.1016/j.bbadis.2010.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.12.014</ArticleId><ArticleId IdType="pmc">PMC3318920</ArticleId><ArticleId IdType="pubmed">21185371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai K., Tsai M., Saito H., Galli S.J. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol. Rev. 2018;282:121&#x2013;150. doi: 10.1111/imr.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12634</ArticleId><ArticleId IdType="pmc">PMC5813811</ArticleId><ArticleId IdType="pubmed">29431212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurish M.F., Austen K.F. Developmental origin and functional specialization of mast cell subsets 1. Immunity. 2012;37:25&#x2013;33. doi: 10.1016/j.immuni.2012.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.07.003</ArticleId><ArticleId IdType="pubmed">22840841</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera A., Beaven M.A., Metcalfe D.D. Mast cells signal their importance in health and disease. J. Allergy Clin. Immunol. 2018;142:381&#x2013;393. doi: 10.1016/j.jaci.2018.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.01.034</ArticleId><ArticleId IdType="pubmed">29454835</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Valent P., Akin C. Mast Cells, Mastocytosis, and Related Disorders. N. Engl. J. Med. 2015;373:163&#x2013;172. doi: 10.1056/NEJMra1409760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1409760</ArticleId><ArticleId IdType="pubmed">26154789</ArticleId></ArticleIdList></Reference><Reference><Citation>Falduto G.H., Pfeiffer A., Luker A., Metcalfe D.D., Olivera A. Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications. Pharmacol. Ther. 2021;220:107718. doi: 10.1016/j.pharmthera.2020.107718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107718</ArticleId><ArticleId IdType="pubmed">33130192</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi-Schaffer F., Gibbs B.F., Hallgren J., Pucillo C., Redegeld F., Siebenhaar F., Vitte J., Mezouar S., Michel M., Puzzovio P.G., et al. Selected recent advances in understanding the role of human mast cells in health and disease. J. Allergy Clin. Immunol. 2022;149:1833&#x2013;1844. doi: 10.1016/j.jaci.2022.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.01.030</ArticleId><ArticleId IdType="pubmed">35276243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolkhir P., Elieh-Ali-Komi D., Metz M., Siebenhaar F., Maurer M. Understanding human mast cells: Lesson from therapies for allergic and non-allergic diseases. Nat. Rev. Immunol. 2022;22:294&#x2013;308. doi: 10.1038/s41577-021-00622-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00622-y</ArticleId><ArticleId IdType="pubmed">34611316</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlin J.S., Maurer M., Metcalfe D.D., Pejler G., Sagi-Eisenberg R., Nilsson G. The ingenious mast cell: Contemporary insights into mast cell behavior and function. Allergy. 2022;77:83&#x2013;99. doi: 10.1111/all.14881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14881</ArticleId><ArticleId IdType="pubmed">33955017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawazeer M.A., Theoharides T.C. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-kappaB, inhibited by methoxyluteolin. Eur. J. Pharmacol. 2019;865:172760. doi: 10.1016/j.ejphar.2019.172760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172760</ArticleId><ArticleId IdType="pubmed">31669588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandere-Grzybowska K., Letourneau R., Kempuraj D., Donelan J., Poplawski S., Boucher W., Athanassiou A., Theoharides T.C. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 2003;171:4830&#x2013;4836. doi: 10.4049/jimmunol.171.9.4830.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.9.4830</ArticleId><ArticleId IdType="pubmed">14568962</ArticleId></ArticleIdList></Reference><Reference><Citation>Taracanova A., Alevizos M., Karagkouni A., Weng Z., Norwitz E., Conti P., Leeman S.E., Theoharides T.C. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. Proc. Natl. Acad. Sci. USA. 2017;114:E4002&#x2013;E4009. doi: 10.1073/pnas.1524845114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1524845114</ArticleId><ArticleId IdType="pmc">PMC5441798</ArticleId><ArticleId IdType="pubmed">28461492</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Petra A.I., Taracanova A., Panagiotidou S., Conti P. Targeting IL-33 in autoimmunity and inflammation. J. Pharmacol. Exp. Ther. 2015;354:24&#x2013;31. doi: 10.1124/jpet.114.222505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.114.222505</ArticleId><ArticleId IdType="pubmed">25906776</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat. Rev. Immunol. 2010;10:103&#x2013;110. doi: 10.1038/nri2692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2692</ArticleId><ArticleId IdType="pubmed">20081870</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Leeman S.E. Effect of IL-33 on de novo synthesized mediators from human mast cells. J. Allergy Clin. Immunol. 2019;143:451. doi: 10.1016/j.jaci.2018.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.09.014</ArticleId><ArticleId IdType="pubmed">30390921</ArticleId></ArticleIdList></Reference><Reference><Citation>Saluja R., Khan M., Church M.K., Maurer M. The role of IL-33 and mast cells in allergy and inflammation. Clin. Transl. Allergy. 2015;5:33. doi: 10.1186/s13601-015-0076-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13601-015-0076-5</ArticleId><ArticleId IdType="pmc">PMC4588911</ArticleId><ArticleId IdType="pubmed">26425339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Asadi S., Weng Z., Sismanopoulos N., Theoharides T.C. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS ONE. 2012;7:e49767. doi: 10.1371/journal.pone.0049767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049767</ArticleId><ArticleId IdType="pmc">PMC3524249</ArticleId><ArticleId IdType="pubmed">23284625</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins L.V., Hajizadeh S., Holme E., Jonsson I.M., Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 2004;75:995&#x2013;1000. doi: 10.1189/jlb.0703328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0703328</ArticleId><ArticleId IdType="pubmed">14982943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sursal T., Adibnia Y., Zhao C., Zheng Y., Li H., Otterbein L.E., Hauser C.J., Itagaki K. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS ONE. 2013;8:e59989. doi: 10.1371/journal.pone.0059989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059989</ArticleId><ArticleId IdType="pmc">PMC3603956</ArticleId><ArticleId IdType="pubmed">23527291</ArticleId></ArticleIdList></Reference><Reference><Citation>Traina G. Mast cells in the brain&#x2014;Old cells, new target. J. Integr. Neurosci. 2017;16:S69&#x2013;S83. doi: 10.3233/JIN-170068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JIN-170068</ArticleId><ArticleId IdType="pubmed">29125499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozniecki J.J., Dimitriadou V., Lambracht-Hall M., Pang X., Theoharides T.C. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 1999;849:1&#x2013;15. doi: 10.1016/S0006-8993(99)01855-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)01855-7</ArticleId><ArticleId IdType="pubmed">10592282</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Konstantinidou A.D. Corticotropin-releasing hormone and the blood-brain-barrier. Front. Biosci. 2007;12:1615&#x2013;1628. doi: 10.2741/2174.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2174</ArticleId><ArticleId IdType="pubmed">17127408</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitriadou V., Rouleau A., Trung Tuong M.D., Newlands G.J., Miller H.R., Luffau G., Schwartz J.C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 1997;77:829&#x2013;839. doi: 10.1016/S0306-4522(96)00488-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(96)00488-5</ArticleId><ArticleId IdType="pubmed">9070755</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrealba F., Riveros M.E., Contreras M., Valdes J.L. Histamine and motivation. Front. Syst. Neurosci. 2012;6:51. doi: 10.3389/fnsys.2012.00051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2012.00051</ArticleId><ArticleId IdType="pmc">PMC3389384</ArticleId><ArticleId IdType="pubmed">22783171</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura H., Shimizume R., Ikegaya Y. Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval. Curr. Top. Behav. Neurosci. 2021;59:329&#x2013;353. doi: 10.1007/7854_2021_253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7854_2021_253</ArticleId><ArticleId IdType="pubmed">34435342</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura D.S., Sultan S., Georgin-Lavialle S., Barete S., Lortholary O., Gaillard R., Hermine O. Evidence for cognitive impairment in mastocytosis: Prevalence, features and correlations to depression. PLoS ONE. 2012;7:e39468. doi: 10.1371/journal.pone.0039468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039468</ArticleId><ArticleId IdType="pmc">PMC3379977</ArticleId><ArticleId IdType="pubmed">22745762</ArticleId></ArticleIdList></Reference><Reference><Citation>Spolak-Bobryk N., Romantowski J., Kujawska-Danecka H., Niedoszytko M. Mastocytosis patients&#x2019; cognitive dysfunctions correlate with the presence of spindle-shaped mast cells in bone marrow. Clin. Transl. Allergy. 2022;12:e12093. doi: 10.1002/clt2.12093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clt2.12093</ArticleId><ArticleId IdType="pmc">PMC8752580</ArticleId><ArticleId IdType="pubmed">35035879</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddaert N., Salvador A., Chandesris M.O., Lemaitre H., Grevent D., Gauthier C., Naggara O., Georgin-Lavialle S., Moura D.S., Munsch F., et al. Neuroimaging evidence of brain abnormalities in mastocytosis. Transl. Psychiatry. 2017;7:e1197. doi: 10.1038/tp.2017.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.137</ArticleId><ArticleId IdType="pmc">PMC5611717</ArticleId><ArticleId IdType="pubmed">28786975</ArticleId></ArticleIdList></Reference><Reference><Citation>Spath-Schwalbe E., Born J., Schrezenmeier H., Bornstein S.R., Stromeyer P., Drechsler S., Fehm H.L., Porzsolt F. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J. Clin. Endocrinol. Metab. 1994;79:1212&#x2013;1214. doi: 10.1210/jcem.79.4.7962296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.79.4.7962296</ArticleId><ArticleId IdType="pubmed">7962296</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Effect of Stress on Neuroimmune Processes. Clin. Ther. 2020;42:1007&#x2013;1014. doi: 10.1016/j.clinthera.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2020.05.002</ArticleId><ArticleId IdType="pubmed">32451121</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito P., Chandler N., Kandere K., Basu S., Jacobson S., Connolly R., Tutor D., Theoharides T.C. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 2002;303:1061&#x2013;1066. doi: 10.1124/jpet.102.038497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.102.038497</ArticleId><ArticleId IdType="pubmed">12438528</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino M., Sapone A., Senger S., Camhi S.S., Kadzielski S.M., Buie T.M., Kelly D.L., Cascella N., Fasano A. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol. Autism. 2016;7:49. doi: 10.1186/s13229-016-0110-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13229-016-0110-z</ArticleId><ArticleId IdType="pmc">PMC5129651</ArticleId><ArticleId IdType="pubmed">27957319</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozniecki J.J., Sahagian G.G., Kempuraj D., Tao K., Jocobson S., Zhang B., Theoharides T.C. Brain metastases of mouse mammary adenocarcinoma is increased by acute stress. Brain Res. 2010;1366:204&#x2013;210. doi: 10.1016/j.brainres.2010.09.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.09.085</ArticleId><ArticleId IdType="pubmed">20887716</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Rozniecki J.J., Sahagian G., Jocobson S., Kempuraj D., Conti P., Kalogeromitros D. Impact of stress and mast cells on brain metastases. J. Neuroimmunol. 2008;205:1&#x2013;7. doi: 10.1016/j.jneuroim.2008.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.09.014</ArticleId><ArticleId IdType="pubmed">18977036</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol. Neurobiol. 2000;20:131&#x2013;147. doi: 10.1023/A:1007074420772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007074420772</ArticleId><ArticleId IdType="pubmed">10696506</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W., Stone K.P., Hsuchou H., Manda V.K., Zhang Y., Kastin A.J. Cytokine signaling modulates blood-brain barrier function. Curr. Pharm. Des. 2011;17:3729&#x2013;3740. doi: 10.2174/138161211798220918.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211798220918</ArticleId><ArticleId IdType="pmc">PMC3939622</ArticleId><ArticleId IdType="pubmed">21834767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed B.A., Christy A.L., Walker M.E., Brown M.A. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: A role for neutrophil recruitment? J. Immunol. 2010;184:6891&#x2013;6900. doi: 10.4049/jimmunol.1000126.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000126</ArticleId><ArticleId IdType="pubmed">20488789</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D. Impact of Inflammation on the Blood-Neural Barrier and Blood-Nerve Interface: From Review to Therapeutic Preview. Int. Rev. Neurobiol. 2017;137:29&#x2013;45. doi: 10.1016/bs.irn.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2017.08.004</ArticleId><ArticleId IdType="pubmed">29132542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibilano R., Frossi B., Pucillo C.E. Mast cell activation: A complex interplay of positive and negative signaling pathways. Eur. J. Immunol. 2014;44:2558&#x2013;2566. doi: 10.1002/eji.201444546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201444546</ArticleId><ArticleId IdType="pubmed">25066089</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Bin N.R., Sugita S. Diverse exocytic pathways for mast cell mediators. Biochem. Soc. Trans. 2018;46:235&#x2013;247. doi: 10.1042/BST20170450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170450</ArticleId><ArticleId IdType="pmc">PMC5986074</ArticleId><ArticleId IdType="pubmed">29472369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilfillan A.M., Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006;6:218&#x2013;230. doi: 10.1038/nri1782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1782</ArticleId><ArticleId IdType="pubmed">16470226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudenzio N., Sibilano R., Marichal T., Starkl P., Reber L.L., Cenac N., McNeil B.D., Dong X., Hernandez J.D., Sagi-Eisenberg R., et al. Different activation signals induce distinct mast cell degranulation strategies. J. Clin. Investig. 2016;126:3981&#x2013;3998. doi: 10.1172/JCI85538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85538</ArticleId><ArticleId IdType="pmc">PMC5096814</ArticleId><ArticleId IdType="pubmed">27643442</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Neuroendocrinology of mast cells: Challenges and controversies. Exp. Dermatol. 2017;26:751&#x2013;759. doi: 10.1111/exd.13288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.13288</ArticleId><ArticleId IdType="pubmed">28094875</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I., Bawazeer M. Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front. Cell. Neurosci. 2019;13:353. doi: 10.3389/fncel.2019.00353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00353</ArticleId><ArticleId IdType="pmc">PMC6687840</ArticleId><ArticleId IdType="pubmed">31427928</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Shi X., Li X., Zou J., Zhou C., Liu W., Shao H., Chen H., Shi L. Neurotransmitter and neuropeptide regulation of mast cell function: A systematic review. J. Neuroinflamm. 2020;17:356. doi: 10.1186/s12974-020-02029-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02029-3</ArticleId><ArticleId IdType="pmc">PMC7691095</ArticleId><ArticleId IdType="pubmed">33239034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumpter T.L., Ho C.H., Pleet A.R., Tkacheva O.A., Shufesky W.J., Rojas-Canales D.M., Morelli A.E., Larregina A.T. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses. J. Allergy Clin. Immunol. 2015;135:1019&#x2013;1030. doi: 10.1016/j.jaci.2014.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.07.036</ArticleId><ArticleId IdType="pmc">PMC4362795</ArticleId><ArticleId IdType="pubmed">25201259</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: From neurotrophin to neurokine. Trends Neurosci. 1996;19:514&#x2013;520. doi: 10.1016/S0166-2236(96)10058-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(96)10058-8</ArticleId><ArticleId IdType="pubmed">8931279</ArticleId></ArticleIdList></Reference><Reference><Citation>Donelan J., Boucher W., Papadopoulou N., Lytinas M., Papaliodis D., Dobner P., Theoharides T.C. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc. Natl. Acad. Sci. USA. 2006;103:7759&#x2013;7764. doi: 10.1073/pnas.0602210103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602210103</ArticleId><ArticleId IdType="pmc">PMC1472518</ArticleId><ArticleId IdType="pubmed">16682628</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Zhang B., Kempuraj D., Tagen M., Vasiadi M., Angelidou A., Alysandratos K.D., Kalogeromitros D., Asadi S., Stavrianeas N., et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc. Natl. Acad. Sci. USA. 2010;107:4448&#x2013;4453. doi: 10.1073/pnas.1000803107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000803107</ArticleId><ArticleId IdType="pmc">PMC2840132</ArticleId><ArticleId IdType="pubmed">20160089</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Betchaku T., Douglas W.W. Somatostatin-induced histamine secretion in mast cells. Characterization of the effect. Eur. J. Pharmacol. 1981;69:127&#x2013;137. doi: 10.1016/0014-2999(81)90407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(81)90407-6</ArticleId><ArticleId IdType="pubmed">6162654</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Douglas W.W. Mast cell histamine secretion in response to somatostatin analogues: Structural considerations. Eur. J. Pharmacol. 1981;73:131&#x2013;136. doi: 10.1016/0014-2999(81)90084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(81)90084-4</ArticleId><ArticleId IdType="pubmed">6171434</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Papaliodis D., Tagen M., Konstantinidou A., Kempuraj D., Clemons A. Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J. Clin. Psychopharmacol. 2005;25:515&#x2013;520. doi: 10.1097/01.jcp.0000193483.89260.a7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jcp.0000193483.89260.a7</ArticleId><ArticleId IdType="pubmed">16282830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990;346:274&#x2013;276. doi: 10.1038/346274a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/346274a0</ArticleId><ArticleId IdType="pubmed">2374592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Alysandratos K.D., Angelidou A., Asadi S., Sismanopoulos N., Delivanis D.A., Weng Z., Miniati A., Vasiadi M., Katsarou-Katsari A., et al. Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis. J. Allergy Clin. Immunol. 2011;127:1522&#x2013;1531.e1528. doi: 10.1016/j.jaci.2011.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.02.005</ArticleId><ArticleId IdType="pmc">PMC3381794</ArticleId><ArticleId IdType="pubmed">21453958</ArticleId></ArticleIdList></Reference><Reference><Citation>Taracanova A., Tsilioni I., Conti P., Norwitz E.R., Leeman S.E., Theoharides T.C. Substance P and IL-33 administered together stimulate a marked secretion of IL-1beta from human mast cells, inhibited by methoxyluteolin. Proc. Natl. Acad. Sci. USA. 2018;115:E9381&#x2013;E9390. doi: 10.1073/pnas.1810133115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810133115</ArticleId><ArticleId IdType="pmc">PMC6176605</ArticleId><ArticleId IdType="pubmed">30232261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Blokhuis B.R., Garssen J., Redegeld F.A. Non-IgE mediated mast cell activation. Eur. J. Pharmacol. 2016;778:33&#x2013;43. doi: 10.1016/j.ejphar.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.07.017</ArticleId><ArticleId IdType="pubmed">26164792</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Kempuraj D., Tagen M., Conti P., Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 2007;217:65&#x2013;78. doi: 10.1111/j.1600-065X.2007.00519.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2007.00519.x</ArticleId><ArticleId IdType="pubmed">17498052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagari E., Tsai M., Lantz C.S., Fox L.G., Galli S.J. Differential release of mast cell interleukin-6 via c-kit. Blood. 1997;89:2654&#x2013;2663. doi: 10.1182/blood.V89.8.2654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V89.8.2654</ArticleId><ArticleId IdType="pubmed">9108382</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Boucher W., Spear K. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int. Arch. Allergy Immunol. 2002;128:344&#x2013;350. doi: 10.1159/000063858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000063858</ArticleId><ArticleId IdType="pubmed">12218373</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockow K., Akin C., Huber M., Metcalfe D.D. IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin. Immunol. 2005;115:216&#x2013;223. doi: 10.1016/j.clim.2005.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2005.01.011</ArticleId><ArticleId IdType="pubmed">15885646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayado A., Teodosio C., Garcia-Montero A.C., Matito A., Rodriguez-Caballero A., Morgado J.M., Muniz C., Jara-Acevedo M., Alvarez-Twose I., Sanchez-Munoz L., et al. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression. Leukemia. 2016;30:124&#x2013;130. doi: 10.1038/leu.2015.176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2015.176</ArticleId><ArticleId IdType="pubmed">26153655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur D., Gomez E., Doe C., Berair R., Woodman L., Saunders R., Hollins F., Rose F.R., Amrani Y., May R., et al. IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: Airway smooth muscle crosstalk. Allergy. 2015;70:556&#x2013;567. doi: 10.1111/all.12593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.12593</ArticleId><ArticleId IdType="pmc">PMC4418379</ArticleId><ArticleId IdType="pubmed">25683166</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 2010;10:440&#x2013;452. doi: 10.1038/nri2782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2782</ArticleId><ArticleId IdType="pmc">PMC4469150</ArticleId><ArticleId IdType="pubmed">20498670</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.T., Wu M.L., Zhang H.J., Su X., Wang J.H. Mast Cell Activation Triggered by Retrovirus Promotes Acute Viral Infection. Front. Microbiol. 2022;13:798660. doi: 10.3389/fmicb.2022.798660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.798660</ArticleId><ArticleId IdType="pmc">PMC8859150</ArticleId><ArticleId IdType="pubmed">35197951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebremeskel S., Schanin J., Coyle K.M., Butuci M., Luu T., Brock E.C., Xu A., Wong A., Leung J., Korver W., et al. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Front. Immunol. 2021;12:650331. doi: 10.3389/fimmu.2021.650331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.650331</ArticleId><ArticleId IdType="pmc">PMC7988091</ArticleId><ArticleId IdType="pubmed">33777047</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta Junior J.D.S., Miggiolaro A., Nagashima S., de Paula C.B.V., Baena C.P., Scharfstein J., de Noronha L. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis. Front. Immunol. 2020;11:574862. doi: 10.3389/fimmu.2020.574862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.574862</ArticleId><ArticleId IdType="pmc">PMC7530169</ArticleId><ArticleId IdType="pubmed">33042157</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M.L., Liu F.L., Sun J., Li X., He X.Y., Zheng H.Y., Zhou Y.H., Yan Q., Chen L., Yu G.Y., et al. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct. Target. Ther. 2021;6:428. doi: 10.1038/s41392-021-00849-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00849-0</ArticleId><ArticleId IdType="pmc">PMC8677926</ArticleId><ArticleId IdType="pubmed">34921131</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J., Anderson D.E., Rathore A.P.S., O&#x2019;Neill A., Mantri C.K., Saron W.A.A., Lee C., Cui C.W., Kang A.E.Z., Foo R., et al. Signatures of mast cell activation are associated with severe COVID-19. medRxiv. 2021 doi: 10.1101/2021.05.31.21255594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.31.21255594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelechowska P., Brzezinska-Blaszczyk E., Agier J., Kozlowska E. Different effectiveness of fungal pathogen-associated molecular patterns (PAMPs) in activating rat peritoneal mast cells. Immunol. Lett. 2022;248:7&#x2013;15. doi: 10.1016/j.imlet.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2022.06.002</ArticleId><ArticleId IdType="pubmed">35679972</ArticleId></ArticleIdList></Reference><Reference><Citation>Krysko O., Bourne J.H., Kondakova E., Galova E.A., Whitworth K., Newby M.L., Bachert C., Hill H., Crispin M., Stamataki Z., et al. Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation. Front. Immunol. 2022;13:968981. doi: 10.3389/fimmu.2022.968981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.968981</ArticleId><ArticleId IdType="pmc">PMC9548604</ArticleId><ArticleId IdType="pubmed">36225927</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi D., Ishiyama K., Suganami M., Ushijima T., Fujii T., Tazoe Y., Kawasaki M., Noguchi K., Makino A. Manganese toxicity disrupts indole acetic acid homeostasis and suppresses the CO(2) assimilation reaction in rice leaves. Sci. Rep. 2021;11:20922. doi: 10.1038/s41598-021-00370-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00370-y</ArticleId><ArticleId IdType="pmc">PMC8536708</ArticleId><ArticleId IdType="pubmed">34686733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler J.B., Butuci M., Wong A., Kamboj A.P., Youngblood B.A. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022;77:1288&#x2013;1291. doi: 10.1111/all.15188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silveira Gorman R., Syed I.U. Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health? Med. Sci. 2022;10:29. doi: 10.3390/medsci10020029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci10020029</ArticleId><ArticleId IdType="pmc">PMC9228930</ArticleId><ArticleId IdType="pubmed">35736349</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D., Cano M., Ma L., Zhou D., Zhu J.H., O&#x2019;Halloran J.A., Goss C., Rauseo A.M., Liu Z., Sahu S.K., et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6:e143299. doi: 10.1172/jci.insight.143299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143299</ArticleId><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Keykavousi K., Nourbakhsh F., Abdollahpour N., Fazeli F., Sedaghat A., Soheili V., Sahebkar A. A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease. Int. J. Anal. Chem. 2022;2022:9006487. doi: 10.1155/2022/9006487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9006487</ArticleId><ArticleId IdType="pmc">PMC9578918</ArticleId><ArticleId IdType="pubmed">36267156</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky S.T., Kochanek P.M., Valadka A.B., Clark R.S.B., Chou S.H., Au A.K., Horvat C., Jha R.M., Mannix R., Wisniewski S.R., et al. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J. Neurotrauma. 2021;38:1&#x2013;43. doi: 10.1089/neu.2020.7332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2020.7332</ArticleId><ArticleId IdType="pmc">PMC7757533</ArticleId><ArticleId IdType="pubmed">33115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Boutajangout A., Masurkar A.V., Betensky R.A., Ge Y., Vedvyas A., Debure L., Moreira A., Lewis A., Huang J., et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer&#x2019;s dementia. Alzheimers Dement. 2022;18:899&#x2013;910. doi: 10.1002/alz.12556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12556</ArticleId><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Waldman M.F., Basavanhally T.J., Jacobs A.R., Lopez G., Perichon R.Y., Ma J.J., Mackenzie E.M., Healy J.B., Wang Y., et al. Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome. J. Transl. Med. 2022;20:486. doi: 10.1186/s12967-022-03682-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03682-3</ArticleId><ArticleId IdType="pmc">PMC9592873</ArticleId><ArticleId IdType="pubmed">36284352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandikattu H.K., Venkateshaiah S.U., Kumar S., Mishra A. IL-15 immunotherapy is a viable strategy for COVID-19. Cytokine Growth Factor Rev. 2020;54:24&#x2013;31. doi: 10.1016/j.cytogfr.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7537239</ArticleId><ArticleId IdType="pubmed">32536564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T., Ma R., Dong W., Teng K.Y., Kollath D.S., Li Z., Yi J., Bustillos C., Ma S., Tian L., et al. Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19. Nat. Commun. 2022;13:2576. doi: 10.1038/s41467-022-30216-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30216-8</ArticleId><ArticleId IdType="pmc">PMC9095674</ArticleId><ArticleId IdType="pubmed">35546150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassianidis G., Siampanos A., Poulakou G., Adamis G., Rapti A., Milionis H., Dalekos G.N., Petrakis V., Sympardi S., Metallidis S., et al. Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19. Int. J. Mol. Sci. 2022;23:4894. doi: 10.3390/ijms23094894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094894</ArticleId><ArticleId IdType="pmc">PMC9099708</ArticleId><ArticleId IdType="pubmed">35563282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K., Nakanishi K., Tsutsui H. Interleukin-18 in Health and Disease. Int. J. Mol. Sci. 2019;20:649. doi: 10.3390/ijms20030649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030649</ArticleId><ArticleId IdType="pmc">PMC6387150</ArticleId><ArticleId IdType="pubmed">30717382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihim S.A., Abubakar S.D., Zian Z., Sasaki T., Saffarioun M., Maleknia S., Azizi G. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. Front. Immunol. 2022;13:919973. doi: 10.3389/fimmu.2022.919973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.919973</ArticleId><ArticleId IdType="pmc">PMC9410767</ArticleId><ArticleId IdType="pubmed">36032110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Xu L., Wang Y., Zhou N., Zhen F., Zhang Y., Qu X., Fan H., Liu S., Chen Y., et al. S100A8/A9 induces microglia activation and promotes the apoptosis of oligodendrocyte precursor cells by activating the NF-kappaB signaling pathway. Brain Res. Bull. 2018;143:234&#x2013;245. doi: 10.1016/j.brainresbull.2018.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.09.014</ArticleId><ArticleId IdType="pubmed">30266587</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg-Hansen P., Vandvik B., Fagerhol M., Holmoy T. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis. J. Neuroimmunol. 2009;216:98&#x2013;102. doi: 10.1016/j.jneuroim.2009.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.09.006</ArticleId><ArticleId IdType="pubmed">19800696</ArticleId></ArticleIdList></Reference><Reference><Citation>Stascheit F., Hotter B., Klose S., Meisel C., Meisel A., Klehmet J. Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity. Front. Neurol. 2021;12:723009. doi: 10.3389/fneur.2021.723009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.723009</ArticleId><ArticleId IdType="pmc">PMC8473624</ArticleId><ArticleId IdType="pubmed">34589050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature. 2008;455:903&#x2013;911. doi: 10.1038/nature07456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07456</ArticleId><ArticleId IdType="pmc">PMC2673233</ArticleId><ArticleId IdType="pubmed">18923512</ArticleId></ArticleIdList></Reference><Reference><Citation>Camporesi E., Lashley T., Gobom J., Lantero-Rodriguez J., Hansson O., Zetterberg H., Blennow K., Becker B. Neuroligin-1 in brain and CSF of neurodegenerative disorders: Investigation for synaptic biomarkers. Acta Neuropathol. Commun. 2021;9:19. doi: 10.1186/s40478-021-01119-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01119-4</ArticleId><ArticleId IdType="pmc">PMC7852195</ArticleId><ArticleId IdType="pubmed">33522967</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort-Gervais J., Provost C., Charbonneau L., Norris C.M., Calon F., Mongrain V., Brouillette J. Neuroligin-1 is altered in the hippocampus of Alzheimer&#x2019;s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers. Sci. Rep. 2020;10:6956. doi: 10.1038/s41598-020-63255-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63255-6</ArticleId><ArticleId IdType="pmc">PMC7181681</ArticleId><ArticleId IdType="pubmed">32332783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Gao X., Qi H., Li J., Zheng Z., Zhang F. Gender differences in cognitive ability associated with genetic variants of NLGN4. Neuropsychobiology. 2010;62:221&#x2013;228. doi: 10.1159/000319948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000319948</ArticleId><ArticleId IdType="pubmed">20714171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Margarucci L.M., Scaramucci E., Orsini M., Salerno G., Di Sante G., Gianfranceschi G., Di Liddo R., Valeriani F., Ria F., et al. Serum S100B protein as a marker of severity in COVID-19 patients. Sci. Rep. 2020;10:18665. doi: 10.1038/s41598-020-75618-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75618-0</ArticleId><ArticleId IdType="pmc">PMC7596559</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Zhu W., Zhang Y., Pan S., Bao J. S100B promotes microglia M1 polarization and migration to aggravate cerebral ischemia. Inflamm. Res. 2018;67:937&#x2013;949. doi: 10.1007/s00011-018-1187-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-018-1187-y</ArticleId><ArticleId IdType="pubmed">30229393</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Wang H., Won S.J., Basu J., Kapfhamer D., Swanson R.A. Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1. Glia. 2016;64:1869&#x2013;1878. doi: 10.1002/glia.23026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23026</ArticleId><ArticleId IdType="pmc">PMC7927976</ArticleId><ArticleId IdType="pubmed">27444121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi R., Kastrisianaki E., Giambanco I., Donato R. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J. Biol. Chem. 2011;286:7214&#x2013;7226. doi: 10.1074/jbc.M110.169342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.169342</ArticleId><ArticleId IdType="pmc">PMC3044978</ArticleId><ArticleId IdType="pubmed">21209080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopman J.H., Santing J.A.L., Foks K.A., Verheul R.J., van der Linden C.M., van den Brand C.L., Jellema K. Biomarker S100B in plasma a screening tool for mild traumatic brain injury in an emergency department. Brain Inj. 2023;37:47&#x2013;53. doi: 10.1080/02699052.2022.2145360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2022.2145360</ArticleId><ArticleId IdType="pubmed">36397287</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahim P., Politis A., van der Merwe A., Moore B., Chou Y.Y., Pham D.L., Butman J.A., Diaz-Arrastia R., Gill J.M., Brody D.L., et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020;95:e610&#x2013;e622. doi: 10.1212/WNL.0000000000009983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009983</ArticleId><ArticleId IdType="pmc">PMC7455357</ArticleId><ArticleId IdType="pubmed">32641538</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J., Park E.S., Colpo G.D., Hinds S.N., Morales D., Ahnstedt H., Paz A.S., Assing A., Liu F., Juneja S., et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J. Neuroinflamm. 2021;18:277. doi: 10.1186/s12974-021-02323-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02323-8</ArticleId><ArticleId IdType="pmc">PMC8627162</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D., Joo S.S., Lee H.J., Choi K.C., Kim S.U., Kim Y.B. Microtubule-associated protein 2, an early blood marker of ischemic brain injury. J. Neurosci. Res. 2012;90:461&#x2013;467. doi: 10.1002/jnr.22769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22769</ArticleId><ArticleId IdType="pubmed">21948028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks C., Dhiman A., Barrymore C., Goswami T. Traumatic Brain Injury Biomarkers, Simulations and Kinetics. Bioengineering. 2022;9:612. doi: 10.3390/bioengineering9110612.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bioengineering9110612</ArticleId><ArticleId IdType="pmc">PMC9687153</ArticleId><ArticleId IdType="pubmed">36354523</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaffaldano P., Ruggieri M., Viterbo R.G., Mastrapasqua M., Trojano M. The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. Brain Behav. Immun. 2014;35:176&#x2013;181. doi: 10.1016/j.bbi.2013.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.08.009</ArticleId><ArticleId IdType="pubmed">23994630</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Y.L., Chong J.R., Raquib A.R., Xu X., Hilal S., Venketasubramanian N., Tan B.Y., Kumar A.P., Sethi G., Chen C.P., et al. Plasma osteopontin as a biomarker of Alzheimer&#x2019;s disease and vascular cognitive impairment. Sci. Rep. 2021;11:4010. doi: 10.1038/s41598-021-83601-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83601-6</ArticleId><ArticleId IdType="pmc">PMC7889621</ArticleId><ArticleId IdType="pubmed">33597603</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifa S., Holmstead R.L., Casida J.E. Toxaphene degradation by iron(II) protoporphyrin systems. J. Agric. Food Chem. 1976;24:277&#x2013;282. doi: 10.1021/jf60204a009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf60204a009</ArticleId><ArticleId IdType="pubmed">3525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e2416. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazarinia D., Behzadifard M., Gholampour J., Karimi R., Gholampour M. Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications. Acta Neurol. Belg. 2022;122:865&#x2013;869. doi: 10.1007/s13760-022-01984-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-01984-3</ArticleId><ArticleId IdType="pmc">PMC9188656</ArticleId><ArticleId IdType="pubmed">35690992</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer D., Guerit S., Puetz T., Khel M.I., Armbrust M., Dunst M., Macas J., Zinke J., Devraj G., Jia X., et al. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke. Acta Neuropathol. 2022;144:305&#x2013;337. doi: 10.1007/s00401-022-02452-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02452-1</ArticleId><ArticleId IdType="pmc">PMC9288377</ArticleId><ArticleId IdType="pubmed">35752654</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Chen R., Wang X., Hu K., Huang L., Lu M., Hu Q. CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention. Front. Cell. Dev. Biol. 2019;7:212. doi: 10.3389/fcell.2019.00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00212</ArticleId><ArticleId IdType="pmc">PMC6781769</ArticleId><ArticleId IdType="pubmed">31632965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tveita A., Murphy S.L., Holter J.C., Kildal A.B., Michelsen A.E., Lerum T.V., Kaarbo M., Heggelund L., Holten A.R., Finbraten A.K., et al. High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in COVID-19. J. Infect. Dis. 2022;226:2150&#x2013;2160. doi: 10.1093/infdis/jiac313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac313</ArticleId><ArticleId IdType="pmc">PMC9384496</ArticleId><ArticleId IdType="pubmed">35876699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner P., McCarberg B.H., Grange L., Kolosov A., Haveric A.L., Zucal V., Petruschke R., Bissonnette S. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim. Care Respir. Med. 2022;32:35. doi: 10.1038/s41533-022-00300-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-022-00300-z</ArticleId><ArticleId IdType="pmc">PMC9489480</ArticleId><ArticleId IdType="pubmed">36127354</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicker J., Alves G., Fonseca C., Falcao A., Fortuna A. Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders. Pharmacol. Res. 2020;162:105226. doi: 10.1016/j.phrs.2020.105226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105226</ArticleId><ArticleId IdType="pubmed">33007420</ArticleId></ArticleIdList></Reference><Reference><Citation>Alegre-Del-Rey E.J., Fenix-Caballero S., Salmeron-Navas F.J., Gil-Sierra M.D., Sierra-Sanchez J.F., Diaz-Alersi Rosety R.L. Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19. Farm. Hosp. 2022;46:166&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">36183210</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimopoulos G., de Mast Q., Markou N., Theodorakopoulou M., Komnos A., Mouktaroudi M., Netea M.G., Spyridopoulos T., Verheggen R.J., Hoogerwerf J., et al. Favorable Anakinra Responses in Severe COVID-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Cell Host Microbe. 2020;28:117&#x2013;123.e111. doi: 10.1016/j.chom.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7221383</ArticleId><ArticleId IdType="pubmed">32411313</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Dong J., Yu Y., Yang X., Shu J., Bao H. Corticosteroids showed more efficacy in treating hospitalized patients with COVID-19 than standard care but the effect is minimal: A systematic review and meta-analysis. Front. Public Health. 2022;10:847695. doi: 10.3389/fpubh.2022.847695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.847695</ArticleId><ArticleId IdType="pmc">PMC9352924</ArticleId><ArticleId IdType="pubmed">35937252</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng B., Ma J., Yang Y., Shao T., Zhao B., Zeng L. Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease. Front. Pharmacol. 2021;12:670170. doi: 10.3389/fphar.2021.670170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.670170</ArticleId><ArticleId IdType="pmc">PMC8187793</ArticleId><ArticleId IdType="pubmed">34122093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Griesel M., Mikolajewska A., Metzendorf M.I., Fischer A.L., Stegemann M., Spagl M., Nair A.A., Daniel J., Fichtner F., et al. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence. Cochrane Database Syst. Rev. 2022;11:CD014963. doi: 10.1002/14651858.CD014963.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014963.pub2</ArticleId><ArticleId IdType="pmc">PMC9670242</ArticleId><ArticleId IdType="pubmed">36385229</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A., Motos A., Cilloniz C., Ceccato A., Fernandez-Barat L., Gabarrus A., Bermejo-Martin J., Ferrer R., Riera J., Perez-Arnal R., et al. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022;48:850&#x2013;864. doi: 10.1007/s00134-022-06726-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06726-w</ArticleId><ArticleId IdType="pmc">PMC9211796</ArticleId><ArticleId IdType="pubmed">35727348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa S.S. Steroid induced secondary immune deficiency. Ann. Allergy Asthma Immunol. 2023 doi: 10.1016/j.anai.2023.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2023.01.010</ArticleId><ArticleId IdType="pubmed">36681272</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Conti P. Dexamethasone for COVID-19? Not so fast. J. Biol. Regul. Homeost. Agents. 2020;34:1241&#x2013;1243. doi: 10.23812/20-EDITORIAL_1-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-EDITORIAL_1-5</ArticleId><ArticleId IdType="pubmed">32551464</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E., Jr., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000;52:673&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pubmed">11121513</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyva-Lopez N., Gutierrez-Grijalva E.P., mbriz-Perez D.L., Heredia J.B. Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases 1. Int. J. Mol. Sci. 2016;17:921. doi: 10.3390/ijms17060921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17060921</ArticleId><ArticleId IdType="pmc">PMC4926454</ArticleId><ArticleId IdType="pubmed">27294919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager A.K., Saaby L. Flavonoids and the CNS. Molecules. 2011;16:1471&#x2013;1485. doi: 10.3390/molecules16021471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16021471</ArticleId><ArticleId IdType="pmc">PMC6259921</ArticleId><ArticleId IdType="pubmed">21311414</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfio C., Gonzalez A., Singh S.K., Rojo L.E., Maccioni R.B. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2020;77:33&#x2013;51. doi: 10.3233/JAD-200443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200443</ArticleId><ArticleId IdType="pubmed">32651325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Thangavel R., Kempuraj D.D., Ahmed M.E., Selvakumar G.P., Raikwar S.P., Zaheer S.A., Iyer S.S., Govindarajan R., Chandrasekaran P.N., et al. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors. 2021;47:190&#x2013;197. doi: 10.1002/biof.1687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1687</ArticleId><ArticleId IdType="pubmed">33098588</ArticleId></ArticleIdList></Reference><Reference><Citation>Calis Z., Mogulkoc R., Baltaci A.K. The Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation. Mini Rev. Med. Chem. 2020;20:1475&#x2013;1488. doi: 10.2174/1389557519666190617150051.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557519666190617150051</ArticleId><ArticleId IdType="pubmed">31288717</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezai-Zadeh K., Ehrhart J., Bai Y., Sanberg P.R., Bickford P., Tan J., Shytle R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflamm. 2008;5:41. doi: 10.1186/1742-2094-5-41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-41</ArticleId><ArticleId IdType="pmc">PMC2569027</ArticleId><ArticleId IdType="pubmed">18817573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S., Kelley K.W., Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA. 2008;105:7534&#x2013;7539. doi: 10.1073/pnas.0802865105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802865105</ArticleId><ArticleId IdType="pmc">PMC2396685</ArticleId><ArticleId IdType="pubmed">18490655</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng Z., Patel A.B., Panagiotidou S., Theoharides T.C. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells. J. Allergy Clin. Immunol. 2015;135:1044&#x2013;1052. doi: 10.1016/j.jaci.2014.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4388775</ArticleId><ArticleId IdType="pubmed">25498791</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelinger G., Merfort I., Schempp C.M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 2008;74:1667&#x2013;1677. doi: 10.1055/s-0028-1088314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1088314</ArticleId><ArticleId IdType="pubmed">18937165</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Conti P., Economu M. Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin. J. Clin. Psychopharmacol. 2014;34:187&#x2013;189. doi: 10.1097/JCP.0000000000000084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000084</ArticleId><ArticleId IdType="pubmed">24525647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashaari Z., Hadjzadeh M.A., Hassanzadeh G., Alizamir T., Yousefi B., Keshavarzi Z., Mokhtari T. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review. J. Mol. Neurosci. 2018;65:491&#x2013;506. doi: 10.1007/s12031-018-1094-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1094-2</ArticleId><ArticleId IdType="pubmed">30083786</ArticleId></ArticleIdList></Reference><Reference><Citation>Dajas F., Rivera-Megret F., Blasina F., Arredondo F., bin-Carriquiry J.A., Costa G., Echeverry C., Lafon L., Heizen H., Ferreira M., et al. Neuroprotection by flavonoids 1. Braz. J. Med. Biol. Res. 2003;36:1613&#x2013;1620. doi: 10.1590/S0100-879X2003001200002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-879X2003001200002</ArticleId><ArticleId IdType="pubmed">14666245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.Y., Lu C.W., Wang S.J. Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats. NeuroToxicology. 2016;55:48&#x2013;57. doi: 10.1016/j.neuro.2016.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.05.008</ArticleId><ArticleId IdType="pubmed">27185356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L.H., Bi W., Qi R.B., Wang H.D., Lu D.X. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int. J. Neurosci. 2011;121:329&#x2013;336. doi: 10.3109/00207454.2011.569040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2011.569040</ArticleId><ArticleId IdType="pubmed">21631167</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezai-Zadeh K., Douglas S.R., Bai Y., Tian J., Hou H., Mori T., Zeng J., Obregon D., Town T., Tan J. Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer&#x2019;s disease beta-amyloid production. J. Cell. Mol. Med. 2009;13:574&#x2013;588. doi: 10.1111/j.1582-4934.2008.00344.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2008.00344.x</ArticleId><ArticleId IdType="pmc">PMC2671567</ArticleId><ArticleId IdType="pubmed">18410522</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z.H., Yao X.L., Zhang Y., Zhang S.F., Hu J.C. Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation. Neurochem. Res. 2018;43:806&#x2013;820. doi: 10.1007/s11064-018-2482-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2482-2</ArticleId><ArticleId IdType="pubmed">29392519</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratton G., Weaver S.R., Burley C.V., Low K.A., Maclin E.L., Johns P.W., Pham Q.S., Lucas S.J.E., Fabiani M., Rendeiro C. Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults. Sci. Rep. 2020;10:19409. doi: 10.1038/s41598-020-76160-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76160-9</ArticleId><ArticleId IdType="pmc">PMC7687895</ArticleId><ArticleId IdType="pubmed">33235219</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi S.A., Chamoli A. Polyphenols as an Effective Therapeutic Intervention Against Cognitive Decline During Normal and Pathological Brain Aging. Adv. Exp. Med. Biol. 2020;1260:159&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">32304034</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Stewart J.M., Hatziagelaki E., Kolaitis G. Brain &#x201c;fog,&#x201d; inflammation and obesity: Key aspects of 2 neuropsychiatric disorders improved by luteolin. Front. Neurosci. 2015;9:225. doi: 10.3389/fnins.2015.00225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00225</ArticleId><ArticleId IdType="pmc">PMC4490655</ArticleId><ArticleId IdType="pubmed">26190965</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Buttiker P., Weissenberger S., Martin A., Ptacek R., Kream R.M. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis. Med. Sci. Monit. 2021;27:e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Guerra L., Patel K. Successful Treatment of a Patient With Severe COVID-19 Using an Integrated Approach Addressing Mast Cells and Their Mediators. Int. J. Infect. Dis. 2022;118:164&#x2013;166. doi: 10.1016/j.ijid.2022.02.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.02.049</ArticleId><ArticleId IdType="pmc">PMC8881225</ArticleId><ArticleId IdType="pubmed">35227867</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam A., Islam M.S., Rahman M.K., Uddin M.N., Akanda M.R. The pharmacological and biological roles of eriodictyol. Arch. Pharm. Res. 2020;43:582&#x2013;592. doi: 10.1007/s12272-020-01243-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-020-01243-0</ArticleId><ArticleId IdType="pubmed">32594426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Liu C., Yuan M. Eriodictyol produces antidepressant-like effects and ameliorates cognitive impairments induced by chronic stress. Neuroreport. 2020;31:1111&#x2013;1120. doi: 10.1097/WNR.0000000000001525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0000000000001525</ArticleId><ArticleId IdType="pubmed">32881773</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Hassan S., Rafiq M., Li H., He Y., Cai Y., Kang X., Liu Z., Yan T. Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone. Evid. Based. Complement. Alternat. Med. 2020;2020:6681352. doi: 10.1155/2020/6681352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6681352</ArticleId><ArticleId IdType="pmc">PMC7752289</ArticleId><ArticleId IdType="pubmed">33414838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokdad-Bzeouich I., Mustapha N., Sassi A., Bedoui A., Ghoul M., Ghedira K., Chekir-Ghedira L. Investigation of immunomodulatory and anti-inflammatory effects of eriodictyol through its cellular anti-oxidant activity. Cell Stress Chaperones. 2016;21:773&#x2013;781. doi: 10.1007/s12192-016-0702-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0702-8</ArticleId><ArticleId IdType="pmc">PMC5003794</ArticleId><ArticleId IdType="pubmed">27250501</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande R.R., Tiwari A.P., Nyayanit N., Modak M. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. Eur. J. Pharmacol. 2020;886:173430. doi: 10.1016/j.ejphar.2020.173430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173430</ArticleId><ArticleId IdType="pmc">PMC7398085</ArticleId><ArticleId IdType="pubmed">32758569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudrapal M., Issahaku A.R., Agoni C., Bendale A.R., Nagar A., Soliman M.E.S., Lokwani D. In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2. J. Biomol. Struct. Dyn. 2022;40:10437&#x2013;10453. doi: 10.1080/07391102.2021.1944909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2021.1944909</ArticleId><ArticleId IdType="pubmed">34182889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton A.T., Gentile F., Hsing M., Ban F., Cherkasov A. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. Mol. Inform. 2020;39:e2000028. doi: 10.1002/minf.202000028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.202000028</ArticleId><ArticleId IdType="pmc">PMC7228259</ArticleId><ArticleId IdType="pubmed">32162456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile F., Fernandez M., Ban F., Ton A.T., Mslati H., Perez C.F., Leblanc E., Yaacoub J.C., Gleave J., Stern A., et al. Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules. Chem. Sci. 2021;12:15960&#x2013;15974. doi: 10.1039/D1SC05579H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1SC05579H</ArticleId><ArticleId IdType="pmc">PMC8672713</ArticleId><ArticleId IdType="pubmed">35024120</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan R., Gourinath S. Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors. J. Proteins Proteom. 2021;12:71&#x2013;80. doi: 10.1007/s42485-021-00059-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42485-021-00059-w</ArticleId><ArticleId IdType="pmc">PMC7985738</ArticleId><ArticleId IdType="pubmed">33776343</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelgawad S.M., Hassab M.A.E., Abourehab M.A.S., Elkaeed E.B., Eldehna W.M. Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review. Front. Pharmacol. 2022;13:879118. doi: 10.3389/fphar.2022.879118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.879118</ArticleId><ArticleId IdType="pmc">PMC9045134</ArticleId><ArticleId IdType="pubmed">35496299</ArticleId></ArticleIdList></Reference><Reference><Citation>Geromichalou E.G., Geromichalos G.D. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2. Molecules. 2022;27:7572. doi: 10.3390/molecules27217572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27217572</ArticleId><ArticleId IdType="pmc">PMC9655607</ArticleId><ArticleId IdType="pubmed">36364398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez A.A., Bullen C.K., Villabona-Rueda A.F., Thompson E.A., Turner M.L., Merino V.F., Yan Y., Kim J., Davis S.L., Komm O., et al. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun. Biol. 2022;5:242. doi: 10.1038/s42003-022-03189-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03189-z</ArticleId><ArticleId IdType="pmc">PMC8933402</ArticleId><ArticleId IdType="pubmed">35304580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>